Page last updated: 2024-10-20

uric acid and Immunoglobulin Light-chain Amyloidosis

uric acid has been researched along with Immunoglobulin Light-chain Amyloidosis in 2 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Immunoglobulin Light-chain Amyloidosis: A nonproliferative disorder of the PLASMA CELL characterized by excessive production and misfolding of IMMUNOGLOBULIN LIGHT CHAINS that form insoluble amyloid fibrils (see AMYLOID DEPOSITS) in various tissues. Clinical features include LIVER FAILURE; MULTIPLE MYELOMA; NEPHROTIC SYNDROME; RESTRICTIVE CARDIOMYOPATHY, and neuropathies.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Yang, T1
Wan, K1
Song, R1
Guo, X1
Xu, Y1
Wang, J1
Zhang, Q1
Alexander, KM1
Liao, R1
Chen, Y1
Kumar, SK1
Gertz, MA1
Lacy, MQ1
Dingli, D1
Hayman, SR1
Buadi, FK1
Short-Detweiler, K1
Zeldenrust, SR1
Leung, N1
Greipp, PR1
Lust, JA1
Russell, SJ1
Kyle, RA1
Rajkumar, SV1
Dispenzieri, A1

Other Studies

2 other studies available for uric acid and Immunoglobulin Light-chain Amyloidosis

ArticleYear
Serum high-density lipoprotein cholesterol serves as a prognostic marker for light-chain cardiac amyloidosis.
    International journal of cardiology, 2021, 02-15, Volume: 325

    Topics: Amyloidosis; Cholesterol; Humans; Immunoglobulin Light-chain Amyloidosis; Lipoproteins, HDL; Prognos

2021
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score.
    Mayo Clinic proceedings, 2011, Volume: 86, Issue:1

    Topics: Amyloidosis; Biomarkers; Female; Follow-Up Studies; Humans; Immunoglobulin Light-chain Amyloidosis;

2011